Helen Pentikis
Fondatore presso Zero Point Five Therapeutics, Inc.
Posizioni attive di Helen Pentikis
Società | Posizione | Inizio | Fine |
---|---|---|---|
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Direttore Tecnico/Scientifico/R&S | - | - |
SAJE Pharma LLC
SAJE Pharma LLC Pharmaceuticals: MajorHealth Technology SAJE Pharma LLC operates as a biopharmaceutical company. It focuses on developing new therapeutic agents that provide significant benefits over available therapies for rare and common diseases with unmet medical needs. The company was founded by Matthews O. Bradley and Helen S. Pentikis in 2011 and is headquartered in Baltimore, MD. | Amministratore Delegato | 01/01/2011 | - |
Direttore Tecnico/Scientifico/R&S | 01/01/2011 | - | |
Fondatore | 01/01/2011 | - | |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Direttore Tecnico/Scientifico/R&S | - | - |
Fondatore | - | - |
Storia della carriera di Helen Pentikis
Precedenti posizioni note di Helen Pentikis
Società | Posizione | Inizio | Fine |
---|---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Helen Pentikis
Wake Forest University | Undergraduate Degree |
University of Maryland | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Chief Tech/Sci/R&D Officer | 5 |
Founder | 3 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Health Technology |
SAJE Pharma LLC
SAJE Pharma LLC Pharmaceuticals: MajorHealth Technology SAJE Pharma LLC operates as a biopharmaceutical company. It focuses on developing new therapeutic agents that provide significant benefits over available therapies for rare and common diseases with unmet medical needs. The company was founded by Matthews O. Bradley and Helen S. Pentikis in 2011 and is headquartered in Baltimore, MD. | Health Technology |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Helen Pentikis
- Esperienza